-
Treatment effects of cladribine tablets on data-driven patterns of regional grey matter atrophy in multiple sclerosis
Barrantes-Cepas, M., Noteboom, S., Colato, E., Battaglini, M., Sormani, M. P., de Stefano, N., Steenwijk, M. D., Koubiyr, I. & Schoonheim, M. M., May 2025, In: Multiple Sclerosis Journal. 31, 6, p. 696-705 10 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Subtypes and location of (juxta)cortical lesions relate to cognitive dysfunction in people with multiple sclerosis
Krijnen, E. A., Kouwenhoven, R.-M., Noteboom, S., Barkhof, F., Uitdehaag, B. M. J., Klawiter, E. C., Steenwijk, M. D., Schoonheim, M. M. & Koubiyr, I., Oct 2024, In: Multiple Sclerosis Journal. 30, 11-12, p. 1556-1560 5 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Long-term neuroprotective effects of natalizumab and fingolimod in multiple sclerosis: Evidence from real-world clinical data
Noteboom, S., Strijbis, E. M. M., Coerver, E. M. E., Colato, E., van Kempen, Z. L. E., Jasperse, B., Vrenken, H., Killestein, J., Schoonheim, M. M. & Steenwijk, M. D., 1 Jul 2024, In: Multiple sclerosis and related disorders. 87, 105670.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
